Trials / Completed
CompletedNCT01453582
Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris
Phase III Study of Total Flavonoids of Propolis Dropping Pill in Angina Pectoris: A Randomized, Double-Blind, Placebo-Controlled Multi-Centered Clinical Trial on Efficacy and Safety.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 478 (actual)
- Sponsor
- Shanghai Greenvalley Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 35 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the efficacy and safety of total flavonoids of propolis dropping pill to treat angina pectoris, evaluated by total exercise time of treadmill exercise test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Total Flavonoids of Propolis dropping pill | One pack contains 30 pills, weight 33g. One pack each time, three times a day, 14 days a course. |
| DRUG | total Flavonoids of Propolis dropping pill | One pack contains 30 pills, weight 33g. One pack each time, three times a day, 14 days a course. |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2014-06-01
- Completion
- 2015-09-01
- First posted
- 2011-10-18
- Last updated
- 2018-02-07
Locations
13 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01453582. Inclusion in this directory is not an endorsement.